These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9446081)

  • 1. [Natural killer cell activity in multiple sclerosis patients].
    Pál E; Varjú G; Vécsei L; Szekeres J; Pálffy G
    Orv Hetil; 1997 Dec; 138(50):3167-70. PubMed ID: 9446081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The regulatory role of natural killer cells in multiple sclerosis.
    Takahashi K; Aranami T; Endoh M; Miyake S; Yamamura T
    Brain; 2004 Sep; 127(Pt 9):1917-27. PubMed ID: 15229129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The natural cytotoxicity system in patients with multiple sclerosis: clinico-immunological parallels].
    Cheknev SB; Latysheva OL; Demina TL; Sorokin AM; Gusev EI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(7):16-9. PubMed ID: 2800805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cell activity in patients with multiple sclerosis given alpha interferon.
    Rice GP; Casali P; Merigan TC; Oldstone MB
    Ann Neurol; 1983 Sep; 14(3):333-8. PubMed ID: 6638954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of immunoregulatory cells and natural killers in the pathogenesis of multiple sclerosis].
    Tunkel' OI; Saidov MZ; Cheredeev AN; Koval'chuk LV; Skriabina EG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(6):880-5. PubMed ID: 6224384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the role of natural killer cell receptors and their human leukocyte antigen ligands in multiple sclerosis.
    Trachtenberg EA
    Ann Neurol; 2009 Jun; 65(6):626-8. PubMed ID: 19557875
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
    Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
    Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regulation of the activity of human natural killer cells by autologous interferon].
    Cheknev SB; Ershov FI; Pritsker AD; Latysheva OL
    Biull Eksp Biol Med; 1994 Sep; 118(9):281-4. PubMed ID: 7819561
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anxiety and physical limitation: a complex relation].
    Léger E; Ladouceur R; Freeston MH
    Encephale; 2002; 28(3 Pt 1):205-9. PubMed ID: 12091780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple sclerosis immunopathic trait and HLA-DR(2)15 as independent risk factors in multiple sclerosis.
    Callander M; Haghighi S; Landtblom AM; Ahlgren CE; Nilsson SI; Rydberg L; Al Khoury H; Rosegren L; Andersen O
    Mult Scler; 2007 May; 13(4):441-5. PubMed ID: 17463066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal analysis of immune cell phenotypes in early stage multiple sclerosis: distinctive patterns characterize MRI-active patients.
    Rinaldi L; Gallo P; Calabrese M; Ranzato F; Luise D; Colavito D; Motta M; Guglielmo A; Del Giudice E; Romualdi C; Ragazzi E; D'Arrigo A; Dalle Carbonare M; Leontino B; Leon A
    Brain; 2006 Aug; 129(Pt 8):1993-2007. PubMed ID: 16870883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer-cell activity after human renal transplantation in relation to killer immunoglobulin-like receptors and human leukocyte antigen mismatch.
    Vampa ML; Norman PJ; Burnapp L; Vaughan RW; Sacks SH; Wong W
    Transplantation; 2003 Oct; 76(8):1220-8. PubMed ID: 14578757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA, molecular mimicry and multiple sclerosis.
    Liblau R; Gautam AM
    Rev Immunogenet; 2000; 2(1):95-104. PubMed ID: 11324698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate immunity modulates autoimmunity: type 1 interferon-beta treatment in multiple sclerosis promotes growth and function of regulatory invariant natural killer T cells through dendritic cell maturation.
    Gigli G; Caielli S; Cutuli D; Falcone M
    Immunology; 2007 Nov; 122(3):409-17. PubMed ID: 17617156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-beta-1a treatment increases CD56bright natural killer cells and CD4+CD25+ Foxp3 expression in subjects with multiple sclerosis.
    Vandenbark AA; Huan J; Agotsch M; La Tocha D; Goelz S; Offner H; Lanker S; Bourdette D
    J Neuroimmunol; 2009 Oct; 215(1-2):125-8. PubMed ID: 19758707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer receptors on CD8 T cells and natural killer cells from different HLA-C phenotypes in melanoma patients.
    Campillo JA; Martínez-Escribano JA; Moya-Quiles MR; Marín LA; Muro M; Guerra N; Parrado A; Campos M; Frías JF; Minguela A; García-Alonso AM; Alvarez-López MR
    Clin Cancer Res; 2006 Aug; 12(16):4822-31. PubMed ID: 16914567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma.
    Bukur J; Rebmann V; Grosse-Wilde H; Luboldt H; Ruebben H; Drexler I; Sutter G; Huber C; Seliger B
    Cancer Res; 2003 Jul; 63(14):4107-11. PubMed ID: 12874014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
    Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell activity in multiple sclerosis.
    Hauser SL; Ault KA; Levin MJ; Garovoy MR; Weiner HL
    J Immunol; 1981 Sep; 127(3):1114-7. PubMed ID: 6167616
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship between the immune system and the diseases of the central nervous system.
    Bokor M; Faragó A; Schnabel R; Garam T
    Ther Hung; 1992; 40(2):51-7. PubMed ID: 1462276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.